Bastian Hengerer
Bastian Hengerer
Boehringer Ingelheim Pharma GmbH & Co- KG
Verified email at boehringer-ingelheim.com
TitleCited byYear
Molecular cloning and expression of brain-derived neurotrophic factor
J Leibrock, F Lottspeich, A Hohn, M Hofer, B Hengerer, P Masiakowski, ...
Nature 341 (6238), 149-152, 1989
16661989
Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non‐NMDA glutamate receptors.
F Zafra, B Hengerer, J Leibrock, H Thoenen, D Lindholm
The EMBO journal 9 (11), 3545-3550, 1990
9511990
Different species of α-synuclein oligomers induce calcium influx and seeding
KM Danzer, D Haasen, AR Karow, S Moussaud, M Habeck, A Giese, ...
Journal of Neuroscience 27 (34), 9220-9232, 2007
6442007
Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos.
B Hengerer, D Lindholm, R Heumann, U Rüther, EF Wagner, H Thoenen
Proceedings of the National Academy of Sciences 87 (10), 3899-3903, 1990
3411990
Novel pharmacological targets for the treatment of Parkinson's disease
AHV Schapira, E Bezard, J Brotchie, F Calon, GL Collingridge, B Ferger, ...
Nature reviews Drug discovery 5 (10), 845-854, 2006
3242006
Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts.
D Lindholm, R Heumann, B Hengerer, H Thoenen
Journal of Biological Chemistry 263 (31), 16348-16351, 1988
2691988
Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology
KM Danzer, SK Krebs, M Wolff, G Birk, B Hengerer
Journal of neurochemistry 111 (1), 192-203, 2009
2322009
Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum
B Ferger, A Leng, A Mura, B Hengerer, J Feldon
Journal of neurochemistry 89 (4), 822-833, 2004
1892004
Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells
E Hermanson, B Joseph, D Castro, E Lindqvist, P Aarnisalo, Å Wallén, ...
Experimental cell research 288 (2), 324-334, 2003
1752003
Transforming growth factor-beta 1 stimulates expression of nerve growth factor in the rat CNS.
D Lindholm, B Hengerer, F Zafra, H Thoenen
Neuroreport 1 (1), 9-12, 1990
1721990
RACK1 is up-regulated in angiogenesis and human carcinomas
H Berns, R Humar, B Hengerer, FN Kiefer, EJ Battegay
The FASEB Journal 14 (15), 2549-2558, 2000
1422000
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degeneration
R Heumann, C Goemans, D Bartsch, K Lingenhöhl, PC Waldmeier, ...
The Journal of cell biology 151 (7), 1537-1548, 2000
1382000
Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition
F Gillardon, W Rist, L Kussmaul, J Vogel, M Berg, K Danzer, N Kraut, ...
Proteomics 7 (4), 605-616, 2007
1192007
Differential regulation of nerve growth factor (NGF) synthesis in neurons and astrocytes by glucocorticoid hormones
D Lindholm, E Castrén, B Hengerer, F Zafra, B Berninger, H Thoenen
European Journal of Neuroscience 4 (5), 404-410, 1992
1071992
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease
S Schuster, A Nadjar, JT Guo, Q Li, C Ittrich, B Hengerer, E Bezard
Journal of Neuroscience 28 (17), 4311-4316, 2008
932008
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
V Grozdanov, C Bliederhaeuser, WP Ruf, V Roth, K Fundel-Clemens, ...
Acta neuropathologica 128 (5), 651-663, 2014
912014
Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS/MND: report on the 142nd ENMC international workshop
AC Ludolph, C Bendotti, E Blaugrund, B Hengerer, JP Löffler, J Martin, ...
Amyotrophic Lateral Sclerosis 8 (4), 217-223, 2007
902007
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3, 4-dihydroxyphenylalanine-induced dyskinesia
S Schuster, E Doudnikoff, D Rylander, A Berthet, I Aubert, C Ittrich, ...
Biological psychiatry 65 (6), 518-526, 2009
792009
Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+) 2-amino-4, 5, 6, 7-tetrahydro-6 …
R Danzeisen, B Schwalenstoecker, F Gillardon, E Buerger, V Krzykalla, ...
Journal of Pharmacology and Experimental Therapeutics 316 (1), 189-199, 2006
772006
Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2, 3-dioxygenase
R Fuertig, D Azzinnari, G Bergamini, F Cathomas, H Sigrist, E Seifritz, ...
Brain, behavior, and immunity 54, 59-72, 2016
702016
The system can't perform the operation now. Try again later.
Articles 1–20